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Background: Acute coronary syndrome (ACS) is associated with
emergency hospitalizations, and there are limited real-world data
on clinical outcomes in Asian post-ACS patients. This paper pre-
sents data on the Indian subgroup from the long term follow-up of
antithrombotic management patterns In Acute CORonary Syn-
drome patients in Asia (EPICOR-Asia) study.
Methods: EPICOR included 12,922 patients with ACS (ST-segment
elevation myocardial infarction [STEMI], non-ST-segment eleva-
tion myocardial infarction [NSTEMI], or unstable angina [UA]).
The study had two phases: acute phase and follow-up phase.
The primary objective was to describe short- and long-
term antithrombotic management patterns (AMPs). Secondary
objectives were to compare the association of AMPs with
clinical outcomes of death and cardiovascular (CV) and bleeding
events.
Results: EPICOR-India enrolled 2468 patients (STEMI – 1482;
NSTEMI – 562; UA – 424). CV risk factors were present in 55% of
the population. Pre-hospital care was received by 35% of
patients, and the average time from symptom onset to ﬁrst
medical attention was approximately 7 h. Thrombolysis was
initiated after admission in 29.1% of STEMI patients, whereas
cardiac catheterization was performed in 74% of the overall
population. The most common drug regimen prescribed during
the acute phase was ≥2 antiplatelets + anticoagulants with no GP
IIb/IIIa inhibitors and at discharge were aspirin + clopidogrel.
Post-discharge outcomes at 2 years included death in 166
(6.7% [STEMI – 6.9%; NSTEMI – 9.6%; UA – 2.4%]), CV events in
177 (7.2% [STEMI – 7.9%; NSTEMI – 8.0%; UA – 3.5%]), composite
events of death, MI, or ischemic stroke in 182 (7.4% [STEMI –
7.6%; NSTEMI – 10.9%; UA – 2.1%]), and bleeding events in 7 (0.3%
[STEMI – 0.3%; NSTEMI – 0.2%; UA – 0.2%]).
Conclusion: This study has observed a gap between international
recommendations and implementation for managing ACS in
Indian patients. The poor pre-hospital care, delay in receiving
medical attention, and fewer doctors opting for non-invasive
interventions are some of the challenges in India. The mortality
along with composite events of death, MI, or ischemic stroke was
highest for NSTEMI patients. The reported CV events were similar
in STEMI and NSTEMI groups. Going forward, steps need to be
taken to improve identiﬁcation, diagnosis, and management of
ACS patients to improve patient outcomes.
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Background: Acute coronary syndrome (ACS) is one of the
leading cause of cardiovascular morbidity and mortality world-
wide. Various scoring systems are available for assessing the
severity of ACS. Many serum markers are under investigation to
assess the severity of ACS. Few of them are rather simple to
assess such as platelet-lymphocyte ratio (PLR), neutrophil-lym-
phocyte ratio (NLR), and non-HDL cholesterol levels. Associa-
tion between these markers and severity of ACS has been
studied in the past and few studies have shown positive cor-
relation between these markers and severity of ACS. However
such association is not established in literature on Indian
patients where there is increasing burden of morbidity and
mortality due to ACS.
Aim: To assess serum PLR, NLR, and serum non-HDL cholesterol
levels in patients with acute coronary syndrome (ACS).
Objective:To study the correlation between serumPLR, NLR, serum
non-HDL cholesterol levels, and severity of ACS.
Methods: This is a prospective study on hospitalized patients with
ACS. ACS was diagnosed based on clinical presentation, ECG, and
cardiac biomarkers. Blood for hemogram and lipid levels was
drawn at admission. Coronary angiography was performed
through the femoral artery access and the angiograms were
evaluated by two interventional cardiologists who were blinded
to the study. The severity of ACSwas assessed by Gensini score. A
total of 86 patientswho presentedwith ACS fromFebruary 2014 to
April 2014 at Kasturba Hospital, Manipal were taken into the
study.
Data analysis and interpretation was done with SPSS 20. A
correlation between Gensini score and PLR, NLR, and non-HDL
cholesterol was established using bivariate correlation analysis
and Spearman's coefﬁcients were calculated. The median Gen-
sini score, median PLR, median NLR, and median non-HDL
cholesterol levels were 56.5, 18.4, 4.94 and 133.67 respectively.
Patients were divided into 3 equal groups based on Gensini
score. Patients with Gensini score ≤40 were categorised as mild,
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≥74 were categorised as severe, and remaining patients were
categorised as moderate. The median PLR, NLR, and non-HDL
cholesterol was calculated for each subgroup and were com-
pared using Mann–Whitney U-test.
Results: We have observed signiﬁcant correlation between PLR
and Gensini score (with Spearman's coefﬁcient of r = 0.727,
p < 0.05) as well as NLR and Gensini score (with Spearman's
coefﬁcient of r = 0.627, p < 0.05). However a correlation could
not be established between non-HDL cholesterol levels and Gen-
sini score (r = 0.49).
The median values of PLR and NLR were signiﬁcantly higher in
the severe group compared to the mild and moderate groups
with p < 0.01 for both PLR and NLR. Non-HDL cholesterol levels
were not found to be signiﬁcantly high or low among the sub-
groups.
Conclusion: We have established statistically signiﬁcant correla-
tion between PLR and NLR with severity of ACS. We recommend
the use of PLR and NLR as markers for severity of ACS. Non-HDL
cholesterol cannot be used as a marker for severity of ACS. Larger
studies are required for further evaluation of these markers as a
tool for assessing severity of ACS.
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Background and aims of the study: The presence of signiﬁcant
atherosclerotic coronary artery disease (CAD) in patients with
valvular heart disease is an important predictor of perioperative
mortality. The prevalence of CAD in patients undergoing valvular
heart surgery is 20–40% in developed countries. We aimed to see
CAD prevalence in our population undergoing valvular heart sur-
gery.
Methods: A total of 1500 patients (1000 males, 500 females; mean
age 52.5  12.9 years) who underwent coronary angiography before
valvular surgery between August 2003 and June 2012 was enrolled
retrospectively. Single valve and multiple valve involvement were
present in 43% and 56% of patients, respectively. Patients with
ischemic mitral regurgitation were excluded from the study. Sig-
niﬁcant CAD was deﬁned as the presence of >/=50% diameter
stenosis in any one of the coronary arteries. The presence of angina
pectoris and of risk factors (e.g. hypertension, smoking, diabetes
mellitus (DM), hyperlipidemia, family history of CAD) were sought
in all patients.
Results: Signiﬁcant CADwas present in 16% of patients (24%males,
9% females) ( p < 0.001); the highest prevalence was in those with
aortic stenosis ( p < 0.05). CAD was not seen in young patients
(aged <45 years) with none of the above-mentioned risk factors.
The highest correlation between CAD and risk factors was family
history of CAD, followed byDM, hyperlipidemia, hypertension, and
smoking in decreasing order.
Conclusion: The study results showed that CAD in patients with
valvular heart disease was less prevalent in our population.
The incidence of coronary lesions rises notably from the age of
50 years in both males and females. Coronary angiography
before valvular heart surgery could be omitted in young patients
(age <45 years) with none of the coronary risk factors, or without
angina.
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Background: Despite major advances in coronary hardware,
particularly the newer generation DES, in-stent restenosis
(ISR) following stent implantation is considered the Achilles'
heel in PCI treatment of CAD. We sought to study demographics
and clinical outcomes of stent restenosis following PCI from our
Institute.
Methods: Patients who underwent PCI between Jan 1 2001 and Dec
31, 2014 at SSSIHMS, Whiteﬁeld, Bangalore and returned with
symptoms suggesting ISR were evaluated as per demographic
parameters, functional status, comorbidities, and echocardio-
graphic parameters, including LVEF, angiographic, and angioplasty
details including type of stent and treatment offered. These were
collected at baseline, and at 9th month follow-up, and till last
known follow-up with us. When patient returned for a second
suspected ISR, they were similarly reevaluated. Angiographic ISR
was classiﬁed as perMehran classiﬁcation applied to both BMS and
DES.
Results: 14,634 patients underwent PCI in the above period, of
whom latest clinical and echocardiographic follow-up was avail-
able in 8317 patients (56.5%). Of these, 371 PCI patients (4.7%)
needed a second procedure for clinical and/or angiographic rest-
enosis (255 patients underwent PCI and 116 patients, CABG). Mean
age of patients was 56.3  9.1 years. Mean LVEF was 48.5  7/5%
during presentation. Among the 371 patients, 217 had a BMS
implanted initial PCI, 124 had DES implanted, and 30 had only
POBA as the initial PCI. The average stent dilation pressure was 14
 4 atm, post dilation was done in >90% of patients at an average
17 atm pressure. Among the 371 patients, average time from PCI to
ﬁrst readmission for restenosis was 334  34 days in CSA patients
(11–12 months) and for ACS patients, 227  18 days (7–9 months),
p < 0.01. CSA was the commonest presenting complaint with ISR
(n = 298) and 73 patients (19.5%) presented to us or elsewhere
with documented ACS (UA = 54, STEMI = 7, NSTEMI = 22). Among
the DES, the initial implanted stent was SES in 51, PES in 69, and
ZES in 4.
The earliest readmission for ISR causing a SAST was 91 days
(3 months, 1 day) in a diabetic patient. On propensity-based uni-
variate analysis, restenosis was more common in diabetics of >5
years duration irrespective of HbA1C status. Also, average stent
size was 2.5 mm vs larger diameter, and interestingly, when stent
size was >2.75 mm, stent length >24 mm became the strongest
predictive factor for future ISR. Male gender, PCI in bifurcation
lesions with two-stent strategy (any technique) vs single stent
strategy, and PCI in CTO lesions, PCI done in low EF (<35%) were
predisposing factors to development of ISR.
The type of ISR as per Mehran angiographic classiﬁcationwas focal
in 92, proliferative in 142, and total in 109 in the ﬁrst event of ISR.
BMS usagewas signiﬁcantly associated (>90% case) with type III/IV
proliferative ISR and more likely needed CABG in repeat admis-
sions while DES ISRwasmore likely to be focal (72% cases) andwas
treated with balloon angioplasty (POBA and scoring balloon in 51).
For the 371 ISR patients, repeat DES stentingwas done as SES = 144,
PES = 76, EES = 15, ZES Endeavour = 16. 18 underwent POBA alone
to ISR lesion, 80were treatedwith repeat BMS stentingwith cutting
balloon-plasty, and 4 patients were treated with DEB and BMS. For
second restenosis, of the 223 patients available till last follow-up,
91 underwent a third angioplasty (75 with DES-SES = 66, EES = 5,
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